rs770074196
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000235.4(LIPA):c.684delT(p.Phe228LeufsTer13) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,613,876 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. F228F) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000235.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- lysosomal acid lipase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, ClinGen, Myriad Women’s Health, Labcorp Genetics (formerly Invitae)
- cholesteryl ester storage diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Wolman diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LIPA | ENST00000336233.10 | c.684delT | p.Phe228LeufsTer13 | frameshift_variant | Exon 7 of 10 | 1 | NM_000235.4 | ENSP00000337354.5 | ||
LIPA | ENST00000428800.5 | c.684delT | p.Phe228LeufsTer13 | frameshift_variant | Exon 6 of 7 | 1 | ENSP00000388415.1 | |||
LIPA | ENST00000371837.5 | c.516delT | p.Phe172LeufsTer13 | frameshift_variant | Exon 6 of 9 | 2 | ENSP00000360903.1 | |||
LIPA | ENST00000456827.5 | c.336delT | p.Phe112LeufsTer13 | frameshift_variant | Exon 5 of 8 | 3 | ENSP00000413019.2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152074Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 250966 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000472 AC: 69AN: 1461802Hom.: 0 Cov.: 32 AF XY: 0.0000413 AC XY: 30AN XY: 727208 show subpopulations
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152074Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74264 show subpopulations
ClinVar
Submissions by phenotype
Lysosomal acid lipase deficiency Pathogenic:2
The c.684del p.(Phe228LeufsTer13) variant in LIPA is a frameshift variant that is predicted to undergo nonsense mediated decay in a gene where loss-of-function is an established disease mechanism (PVS1_VERY STRONG). This variant has been detected in multiple individuals with a clinical diagnosis of Lysosomal Acid Lipase Deficiency who also carried a second pathogenic/ likely pathogenic LIPA variant (PM3_STRONG, PP4_SUPPORTING; PMIDs 10562460, 10627498, 31412917, 34020687). The highest population minor allele frequency in gnomAD v2.1.1 is 0.00001763 in European (non-Finnish) population (PM2_MODERATE). Functional studies demonstrate impaired LAL enzyme activity (PS3_STRONG; PMIDs 10562460, 29196158, 31180157). Based on the evidence listed above, this variant has been classified as pathogenic. -
- -
Wolman disease Pathogenic:1
This sequence change creates a premature translational stop signal (p.Phe228Leufs*13) in the LIPA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LIPA are known to be pathogenic (PMID: 23485521). This variant is present in population databases (rs770074196, gnomAD 0.007%). This premature translational stop signal has been observed in individuals with cholesteryl ester storage disease (PMID: 10562460, 10627498). ClinVar contains an entry for this variant (Variation ID: 553192). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects LIPA function (PMID: 29196158). For these reasons, this variant has been classified as Pathogenic. -
Cholesteryl ester storage disease Pathogenic:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at